[go: up one dir, main page]

OA09358A - Dérivés azoliques. - Google Patents

Dérivés azoliques.

Info

Publication number
OA09358A
OA09358A OA60010A OA60010A OA09358A OA 09358 A OA09358 A OA 09358A OA 60010 A OA60010 A OA 60010A OA 60010 A OA60010 A OA 60010A OA 09358 A OA09358 A OA 09358A
Authority
OA
OAPI
Prior art keywords
azolic derivatives
azolic
derivatives
Prior art date
Application number
OA60010A
Other languages
English (en)
Inventor
Caulkett Peter William Rodney
Jones Geraint
Collis Michael George
Poucher Simon Martin
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909011913A external-priority patent/GB9011913D0/en
Priority claimed from GB909011914A external-priority patent/GB9011914D0/en
Priority claimed from GB919101379A external-priority patent/GB9101379D0/en
Priority claimed from GB919101380A external-priority patent/GB9101380D0/en
Priority claimed from GB919104125A external-priority patent/GB9104125D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of OA09358A publication Critical patent/OA09358A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA60010A 1990-05-29 1991-05-29 Dérivés azoliques. OA09358A (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB909011913A GB9011913D0 (en) 1990-05-29 1990-05-29 Azole derivatives
GB909011914A GB9011914D0 (en) 1990-05-29 1990-05-29 Heterocyclic compounds
GB919101379A GB9101379D0 (en) 1991-01-22 1991-01-22 Heterocyclic compounds
GB919101380A GB9101380D0 (en) 1991-01-22 1991-01-22 Azole derivatives
GB919104125A GB9104125D0 (en) 1991-02-27 1991-02-27 Azole derivatives

Publications (1)

Publication Number Publication Date
OA09358A true OA09358A (fr) 1992-09-15

Family

ID=27516979

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60010A OA09358A (fr) 1990-05-29 1991-05-29 Dérivés azoliques.

Country Status (20)

Country Link
US (1) US5270311A (fr)
EP (1) EP0459702A1 (fr)
JP (1) JP2504879B2 (fr)
KR (1) KR910020012A (fr)
CN (1) CN1056879A (fr)
AP (1) AP248A (fr)
AU (1) AU642494B2 (fr)
CA (1) CA2043424A1 (fr)
CS (1) CS159591A3 (fr)
FI (1) FI912563A (fr)
GB (1) GB2244487B (fr)
HU (1) HUT61311A (fr)
IE (1) IE911818A1 (fr)
IL (1) IL98316A (fr)
NO (1) NO178401C (fr)
NZ (1) NZ238288A (fr)
OA (1) OA09358A (fr)
PT (1) PT97776A (fr)
RO (1) RO109542B1 (fr)
YU (1) YU47812B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9226735D0 (en) * 1992-12-22 1993-02-17 Ici Plc Azole derivatives
EP0459702A1 (fr) * 1990-05-29 1991-12-04 Zeneca Limited Dérivés d'azoles
US5356894A (en) * 1990-05-29 1994-10-18 Rodney Peter W Morpholinyl substituted [1,2,4]-triazolo[1,5-a]triazine as antagonist
GB9111131D0 (en) * 1991-05-23 1991-07-17 Ici Plc Heterocyclic compounds
GB9111130D0 (en) * 1991-05-23 1991-07-17 Ici Plc Azole derivatives
GB9124968D0 (en) * 1991-11-25 1992-01-22 Ici Plc Chemical process
GB9125002D0 (en) * 1991-11-25 1992-01-22 Ici Plc Azole derivatives
GB9125001D0 (en) * 1991-11-25 1992-01-22 Ici Plc Heterocyclic compounds
DE69428977T2 (de) * 1993-07-27 2002-07-11 Kyowa Hakko Kogyo Co., Ltd. Arzneimittel gegen Parkinsonsche Krankheit
US5789407A (en) * 1993-09-06 1998-08-04 Kyowa Hakko Kogyo Co., Ltd. Method of treating depression with certain triazine derivatives
JP4195729B2 (ja) * 1997-03-24 2008-12-10 協和醗酵工業株式会社 [1,2,4]トリアゾロ[1,5−c]ピリミジン誘導体
US6060481A (en) * 1998-05-28 2000-05-09 The Penn State Research Foundation Method for improving insulin sensitivity using an adenosine receptor antagonist
NZ510629A (en) * 1998-09-22 2003-04-29 Kyowa Hakko Kogyo Kk [1,2,4]Triazolo[1,5-c]pyrimidine derivatives and pharmaceutical use as adenosine A2A receptor antagonists
EP1544200A1 (fr) * 2002-09-24 2005-06-22 Kyowa Hakko Kogyo Co., Ltd. D riv de 1,2,4]-triazolo 1,5]pyrimidine
US7329658B2 (en) * 2003-02-06 2008-02-12 Pfizer Inc Cannabinoid receptor ligands and uses thereof
EP1633756B1 (fr) 2003-04-09 2008-12-24 Biogen Idec MA Inc. Antagonistes de recepteur d'adenosine a2a
EP1615930A2 (fr) 2003-04-09 2006-01-18 Biogen Idec MA, Inc. Triazolotriazines et pyrazolotriazines et leurs procedes de fabrication et d'utilisation
EP1615931A1 (fr) 2003-04-09 2006-01-18 Biogen Idec MA Inc. Triazolopyrazines et procedes de preparation et d'utilisation ce celles-ci
WO2004092172A2 (fr) * 2003-04-09 2004-10-28 Biogen Idec Ma Inc. Triazolo[1,5-c]pyrimidines et pyrazolo[1,5-c]pyrimidines et procedes de preparation et d'utilisation de celles-ci
WO2004110454A1 (fr) * 2003-06-13 2004-12-23 Ishihara Sangyo Kaisha, Ltd. Composition de traitement ou de prevention de maladies necessitant l'administration d'un agoniste du recepteur a2a de l'adenosine
EP1856053A1 (fr) 2005-01-14 2007-11-21 Millennium Pharmaceuticals, Inc. Derives de cinnamide et d'hydrocinnamide presentant une activite inhibitrice de raf-kinase
EP2920417A1 (fr) 2012-12-06 2015-09-23 Siemens Aktiengesellschaft Système et procédé permettant de faire entrer de la chaleur dans une formation géologique par induction électromagnétique
CN106916073A (zh) * 2017-01-20 2017-07-04 上海巧坤化工科技有限公司 一种大麦芽碱盐酸盐的合成方法
WO2019154294A1 (fr) * 2018-02-06 2019-08-15 江苏恒瑞医药股份有限公司 Dérivé de pyrazolo[1,5-a][1,3,5]triazine-2-amine, son procédé de préparation et son utilisation médicale
EP3814355A4 (fr) * 2018-06-26 2022-06-08 Zhejiang Vimgreen Pharmaceuticals, Ltd Dérivés de triazolotriazine en tant qu'antagonistes du récepteur a2a
JP7197206B2 (ja) * 2018-06-26 2022-12-27 チョーチヤン ビムグリーン ファーマシューティカルズ、リミテッド A2a受容体拮抗薬として用いられるトリアゾロトリアジン誘導体
BE1026602B1 (fr) 2018-09-27 2020-06-18 Iteos Therapeutics S A Inhibiteurs d’a2a ne penetrant pas dans le cerveau et methodes d’utilisation dans le traitement de cancers
CN111205291B (zh) * 2018-11-22 2022-08-23 上海科技大学 三唑并环类化合物、其制备方法、中间体和应用
CN112500416B (zh) * 2019-07-30 2021-12-17 厦门宝太生物科技股份有限公司 一种吡唑并三嗪类化合物中间体的制备方法
US20230048888A1 (en) * 2019-12-26 2023-02-16 Zhejiang Vimgreen Pharmaceuticals, Ltd. Use of triazolotriazine derivative in treatment of diseases

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3846423A (en) * 1972-06-08 1974-11-05 Icn Pharmaceuticals Pyrazolo (1,5a) 1,3,5-triazines
ZA743316B (en) * 1973-05-22 1976-01-28 Sandoz Ltd Improvements in or relating to organic compounds
US3995039A (en) * 1975-05-27 1976-11-30 Merck & Co., Inc. Pyrazolo [1,5-a] [1,3,5] triazines
GB1579932A (en) * 1976-05-12 1980-11-26 Ici Ltd Herbicidal triazolotriazines
GB2016002B (en) * 1978-01-09 1982-05-06 Aron Sa Amino derivatives of pyrazolo(1,5-a)s triazine
AU2192683A (en) * 1982-12-30 1984-07-05 Biomeasure Incorporated Pyrazolo(1,5-alpha)-1,3,5-triazines
CA1267143A (fr) * 1985-06-06 1990-03-27 Sun H. Kim Derives de 7-phenylpyrazole[1,5-a]-1,3,5-triazine, agents anti-arthrite
DE3677445D1 (de) * 1985-09-30 1991-03-14 Ciba Geigy Ag 2-substituierte-e-kondensierte(1,5-c)-pyrimidine, pharmazeutische zubereitungen und ihre verwendung.
WO1988002370A1 (fr) * 1986-09-30 1988-04-07 Ciba-Geigy Ag Triazolo-1,5-c pyrimidines-1,2,4 substituees en position 2 et accolees en face e
US4824834A (en) * 1986-10-31 1989-04-25 Otsuka Pharmaceutical Company, Limited Pyrazolotriazine compounds
US4734413A (en) * 1987-03-02 1988-03-29 Riker Laboratories, Inc. Substituted 1,2,4-triazolo[1,5-A]triazines as bronchodilators
DE3885357T2 (de) * 1987-06-29 1994-03-24 Duphar Int Res Anellierte Indolderivate.
DE8817122U1 (de) * 1988-12-22 1993-02-04 Boehringer Ingelheim Kg, 55218 Ingelheim Neue Xanthinderivate mit Adenosinantogenistischer Wirkung
US4970142A (en) * 1989-02-16 1990-11-13 Konica Corporation Silver halide photographic light-sensitive material containing cyan coupler
EP0459702A1 (fr) * 1990-05-29 1991-12-04 Zeneca Limited Dérivés d'azoles

Also Published As

Publication number Publication date
CA2043424A1 (fr) 1991-11-30
YU47812B (sr) 1996-01-09
AU7734891A (en) 1991-12-05
EP0459702A1 (fr) 1991-12-04
AP248A (en) 1993-03-16
NO912051D0 (no) 1991-05-28
PT97776A (pt) 1992-03-31
GB2244487A (en) 1991-12-04
GB2244487B (en) 1994-02-02
KR910020012A (ko) 1991-12-19
JPH0597855A (ja) 1993-04-20
FI912563A (fi) 1991-11-30
CN1056879A (zh) 1991-12-11
YU94791A (sh) 1994-06-24
NO912051L (no) 1991-12-02
AP9100266A0 (en) 1991-07-31
RO109542B1 (ro) 1995-03-30
IE911818A1 (en) 1991-12-04
NZ238288A (en) 1993-07-27
IL98316A (en) 1995-05-26
AU642494B2 (en) 1993-10-21
HUT61311A (en) 1992-12-28
JP2504879B2 (ja) 1996-06-05
NO178401B (no) 1995-12-11
GB9111132D0 (en) 1991-07-17
CS159591A3 (en) 1992-01-15
US5270311A (en) 1993-12-14
NO178401C (no) 1996-03-20
FI912563A0 (fi) 1991-05-28
HU911789D0 (en) 1991-12-30
IL98316A0 (en) 1992-06-21

Similar Documents

Publication Publication Date Title
OA09358A (fr) Dérivés azoliques.
DE59108494D1 (de) 1-H-3-Aryl-pyrrolidin-2,4-dion-Derivate
NL300250I1 (nl) Chinuclidinederivaten.
FI923931A0 (fi) Anordning foer granskning av insidan av en foergrenad roerlinje.
DE69112037D1 (de) Waferträger.
DE69110254D1 (de) Hydroxychinolonderivate.
ITTO910939A0 (it) Derivato di alfa-ossoacetammide.
DE69103503D1 (de) Adriamycinderivate.
DZ1514A1 (fr) Dérivés de benzèneacetamides.
FI911161A0 (fi) C-bindade pyrazolderivat.
NO911213L (no) Undervannsbroenn-koplingsmekanisme.
ATE115560T1 (de) Acetamidderivate.
DE69111876D1 (de) Ophthalmometer.
DE59104521D1 (de) Polkern.
DE69108314D1 (de) Dihydro-Campholen-Aldehydderivate.
DE69100071D1 (de) Kaefigmutter.
FI913179A0 (fi) Aminosyraderivat.
DE59106761D1 (de) N-Acylpyrrolidin-Derivate.
DE69114601D1 (de) Phenytoinderivate.
ATE124392T1 (de) 8-sulfamylmethylen-2-aminotetraline.
DE59105769D1 (de) Alkyloxypropenyl Derivate.
DE59103525D1 (de) Honmachine.
DE59103481D1 (de) o-Aminoazoverbindungen.
DE69109531D1 (de) 4-Piperidinyl-ergolin-Derivate.
DE69104013D1 (de) Hexitolderivate.